Sales & Marketing News | pharmaphorum

News

Lilly ups spend on diabetes, obesity drug production to $9bn

Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indian

News

Cytokinetics eyes go-it-alone strategy for aficamten

Cytokinetics has been a top biotech takeover candidate for some time, thanks to blockbuster speculation about its lead drug aficamten, but a $1 billion-plus set of financi

News

Second fire at Novo Nordisk in a week now under control

Firefighters have been able to extinguish a fire that raged through an office building at the site of Novo Nordisk’s headquarters in Denmark, although it will not survive

News

Aerial vew of Discovery Park in Sandwich, Kent

Chinese firm throws lifeline to Pfizer UK plant workers

China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer UK manufacturing facility in Sandwich, Kent, safeguarding dozens of jobs.

News

Merck builds in cell, gene therapies with Mirus Bio deal

Germany’s Merck KGaA has agreed to acquire Mirus Bio, a specialist in transfection reagents used in the production of cell and gene therapies (CGTs), in a deal valued at a

News

Click buys Better assets to speed its digital obesity drive

Click Therapeutics has snapped up the assets of troubled digital health company Better Therapeutics, including its FDA-approved prescription digital therapeutic (PDT) for

Lilly ups spend on diabetes, obesity drug production to $9bn

Cytokinetics eyes go-it-alone strategy for aficamten

Second fire at Novo Nordisk in a week now under control

Chinese firm throws lifeline to Pfizer UK plant workers

Merck builds in cell, gene therapies with Mirus Bio deal

Click buys Better assets to speed its digital obesity drive

AI giant Anthropic buys Coefficient Bio for $400m

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks